Borealis selects IMCD for bormed distribution across Americas

Borealis selects IMCD for bormed distribution across Americas

By: ICN Bureau

Last updated : August 05, 2025 11:11 am



This agreement covers the United States, Canada, Mexico, Central America, and the Caribbean


Borealis announce that IMCD, a global specialty chemicals and ingredients provider, has become its official distribution partner for the Bormed portfolio in the Americas.

Effective August 1, 2025, this agreement covers the United States, Canada, Mexico, Central America, and the Caribbean, greatly enhancing access to Borealis’ dedicated healthcare polyolefins throughout the region.

The partnership includes the entire Bormed portfolio—a selection of specialized polyethylene and polypropylene grades designed for medical devices, pharmaceutical packaging, and diagnostic applications. These materials support a wide range of processing technologies, such as injection molding for medical and diagnostic markets. Backed by decades of healthcare expertise, the portfolio is founded on the core principles of the Bormed Concept: service, commitment, and conformance.

“Expanding our partnership with IMCD into the Americas marks a key milestone in our We4Customers strategy. It strengthens our regional presence and ensures the Bormed portfolio is represented by a partner with the expertise and network needed to serve this vital market.”

Paulo Cavacas, Borealis Head of Marketing Advanced Products, commented: “IMCD brings extensive expertise in polyolefins for healthcare applications along with a strong infrastructure across the Americas. This new agreement builds on the successful partnership launched in 2021, when IMCD became Borealis’ Bormed distributor in most European markets. Extending this model to the Americas underscores our shared commitment to addressing the global healthcare industry’s needs for reliable supply, regulatory compliance, and ongoing innovation.”

Marc Gauthier, IMCD Global Principal Manager, Medical, added: “We’re proud to expand our collaboration with Borealis and deliver the Bormed portfolio to customers throughout the Americas. This partnership enables us to support customers with high-quality materials, expert technical guidance, and dependable local service—everything required to meet the stringent regulatory and performance standards of the healthcare sector.”

Borealis IMCD

First Published : August 05, 2025 12:00 am